Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1983-09-20
1986-08-05
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
435 68, 435811, 530351, A61K 3702, C07K 1300, C12P 2100
Patent
active
046042849
ABSTRACT:
An active fragment of human immune interferon and a method for the extraction and purification of this protein fragment is disclosed. This method permits the purification to homogenity of the active fragment of recombinant human immune interferon.
REFERENCES:
patent: 4432895 (1984-02-01), Tarnowski
patent: 4457867 (1984-07-01), Ishida
patent: 4476049 (1984-10-01), Kung
patent: 4485017 (1984-11-01), Tan et al.
Gray et al., Nature, vol. 295, pp. 503-509, 1982.
Hochkeppel, Nature, vol. 296, pp. 258-259, 1982.
Staehelin et al., J. Biol. Chem., vol. 256, pp. 9750-9754, 1981.
Capon et al., The Third Annual International Congress for Interferon Research, 1982, Miami, Fla.
Honda Susumu
Kung Hsiang-Fu
Sugino Hiromu
Epstein William H.
Gould George M.
Hazel Blondel
Hoffmann-La Roche Inc.
Saxe Jon S.
LandOfFree
Homogeneous immune interferon fragment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Homogeneous immune interferon fragment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Homogeneous immune interferon fragment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-968411